Providence St. Joseph Health, a large network of hospitals and clinics headquartered in Renton, WA, said Thursday it plans to acquire Bluetree Network, a consultancy that specializes in projects involving electronic health records software.
Providence did not say how much it... Read more »
IBM’s acquisition of open-source software maker Red Hat cleared the hurdle of approval from European regulators Thursday because it raised no concerns about competition, according to the European Commission.
The $34 billion deal, which the companies plan on closing in the... Read more »
Degreed, which helps businesses upgrade the skills of their staffers through an online gateway to learning resources, announced Thursday it has raised $75 million to grow the service and expand internationally.
San Francisco-based Degreed is among the educational technology companies... Read more »
Rare disease drug developer BridgeBio is now a public company, raising $348.5 million in the biggest biotech IPO so far this year.
On Wednesday night, BridgeBio priced its stock offering of 20.5 million shares at $17 each, topping the $14 to... Read more »
If biotech’s historic bull run is losing steam, as some observers believe, this week is one hell of a final stampede.
Adaptive Biotechnologies of Seattle just raised $300 million. BridgeBio Pharma of Palo Alto, CA, has topped it, raising $348.5... Read more »
Even as Uber, Lyft, and other high-profile initial public offerings underperformed out of the gate, the average share price of companies that have gone public in the US this year is up by almost 33 percent.
That’s according to data based... Read more »
[Updated, 10:11 am ET, see below.] Pharmaceutical giant AbbVie this morning agreed to acquire Allergan in a $63 billion deal meant to provide the pharmaceutical giant with enough revenue to brace for the loss of patent protection for the... Read more »
To hear some people talk, you’d think the age of bipartisan action in Congress was a lost phenomenon of the distant past. But it’s not so, at least when it comes to certain issues. And no one knows it better than... Read more »
Youth. Charm. Fearlessness. Ruthless focus. These can be positive attributes in an entrepreneur, but in a more rational world, technology investors wouldn’t overvalue them. Risk capital would be allocated based mostly on evidence, data, progress towards milestones—in short, on proof.
In... Read more »